— Know what they know.
Not Investment Advice

ETNB NASDAQ

89bio, Inc.
1W: +0.3% 1M: +1.0% 3M: +62.0% 1Y: +85.0% 3Y: +69.8% 5Y: -39.3%
$14.84
Last traded 2025-10-30 — delisted
NASDAQ · Healthcare · Biotechnology · $2.2B mcap · 146M float · 3.69% daily turnover · Short 23% of daily vol

Balance Sheet Trends

Total Assets
$479M -19.7% ▼
5Y CAGR: +38.0%
Total Liabilities
$78M +29.9% ▲
5Y CAGR: +69.2%
Shareholders Equity
$401M -25.3% ▼
5Y CAGR: +34.8%
Cash & Investments
$440M -24.0% ▼
5Y CAGR: +36.3%
Total Debt
$38M +38.5% ▲
Net Debt
-$89M +69.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$98M$52M$55M$316M$126M
Short-Term Investments$106M$98M$133M$263M$314M
Cash & ST Investments$205M$151M$188M$579M$440M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$210M$162M$196M$594M$476M
Property, Plant & Equip.$166K$150K$455K$2M$2M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$706K$290K$289K$396K$640K
Total Non-Current Assets$872K$440K$744K$3M$2M
Total Assets$211M$162M$197M$596M$479M
— Liabilities —
Accounts Payable$2M$7M$13M$9M$15M
Short-Term Debt$0$2M$168K$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$7M$8M$14M$7M
Total Current Liabilities$8M$20M$25M$30M$36M
Long-Term Debt$0$17M$20M$25M$36M
Other Non-Current Liab.$0$30K$0$4M$5M
Total Non-Current Liabilities$0$17M$20M$30M$42M
Total Liabilities$8M$36M$45M$60M$78M
— Equity —
Common Stock$20K$20K$51K$93K$120K
Retained Earnings-$123M-$213M-$315M-$457M-$825M
Accumulated OCI-$10K-$64K-$350K$190K$563K
Total Stockholders Equity$203M$126M$152M$536M$401M
Total Liabilities & Equity$211M$162M$197M$596M$479M
— Key Metrics —
Total Debt$0$19M$21M$27M$38M
Net Debt-$205M-$131M-$35M-$289M-$89M
Total Investments$106M$98M$133M$263M$314M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms